FY25 revenue in line and positive adjusted EBITDA Positioned to return to growth in 2026
hVIVO plc (AIM: HVO) Notice of Trading Update
Notice of Trading Update
hVIVO plc (AIM: HVO) plays key role in $9.2bn Cidara takeover by MSD
hVIVO plc has highlighted a major validation of its clinical capabilities after its client Cidara Therapeutics agreed to be acquired by pharmaceutical giant MSD in a deal worth approximately $9.2
hVIVO plc (AIM: HVO) secures £5m+ in new clinical trial contracts
hVIVO plc has announced that its German subsidiary, CRS, has landed more than £5 million in new contracts since September, driven in large part by two returning mid-sized German pharmaceutical
hMPV Interview with Guy Boivin & hVIVO’s Chief Scientific Officer
Join us for an insightful conversation on hMPV featuring our Chief Scientific Officer, Dr Andrew Catchpole and Guy Boivin, a professor from Laval University and one of the founding fathers
hVIVO plc: Diversification in Action as 2026 Growth Beckons
After a turbulent year for the clinical research sector, hVIVO plc (AIM: HVO) has found itself back in penny-stock territory. Its share price, which stood at 29.8 GBX in November
hVIVO plc: Diversification in Action as 2026 Growth Beckons
After a turbulent year for the clinical research sector, hVIVO plc (AIM: HVO) has found itself back in penny-stock territory. Its share price, which stood at 29.8 GBX in November
hVIVO plc (AIM: HVO) Positive data from novel human challenge models
Positive data from multiple novel human challenge models hVIVO presentations made at influential ESWI and World Vaccine Congress Europe conferences
hVIVO plc (AIM: HVO) Presentation at Jefferies Healthcare Conference
hVIVO to present at Jefferies Global Healthcare Conference
European Green Transition (AIM: EGT) Option Agreement to Sell Pajala Copper Project
European Green Transition (AIM: EGT), a company seeking to acquire and transform revenue stage businesses supporting the green energy transition in Europe, announces that it has entered into an exclusive
European Green Transition (AIM: EGT) Appointment of Independent Non-Executive Director
European Green Transition (AIM: EGT), a company seeking to acquire and transform revenue stage businesses supporting the green energy transition in Europe, announces the appointment of Mick Kearney as an
European Green Transition: From Exploration to Execution at The Investor Summit
A Company in Transition